Switching from protease inhibitor-based-HAART to a protease inhibitor-sparing regimen is associated with improved specific HIV-immune responses in HIV-infected children
about
Therapeutic DNA vaccination of vertically HIV-infected children: report of the first pediatric randomised trial (PEDVAC)Immunotherapy with an HIV-DNA Vaccine in Children and Adults.Gag-Specific CD4 and CD8 T-Cell Proliferation in Adolescents and Young Adults with Perinatally Acquired HIV-1 Infection Is Associated with Ethnicity - The ANRS-EP38-IMMIP Study.Cytometry, immunology, and HIV infection: three decades of strong interactions.Short communication: enhanced CD8+ T cell apoptosis in HIV-infected adolescents with virologic failure on protease inhibitor-based therapy.
P2860
Switching from protease inhibitor-based-HAART to a protease inhibitor-sparing regimen is associated with improved specific HIV-immune responses in HIV-infected children
description
article
@en
im September 2006 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у вересні 2006
@uk
name
Switching from protease inhibi ...... onses in HIV-infected children
@en
Switching from protease inhibi ...... onses in HIV-infected children
@nl
type
label
Switching from protease inhibi ...... onses in HIV-infected children
@en
Switching from protease inhibi ...... onses in HIV-infected children
@nl
prefLabel
Switching from protease inhibi ...... onses in HIV-infected children
@en
Switching from protease inhibi ...... onses in HIV-infected children
@nl
P2093
P50
P1433
P1476
Switching from protease inhibi ...... onses in HIV-infected children
@en
P2093
Elio Freda
Guido Castelli-Gattinara
Maria Luisa Romiti
Simone Pensieroso
P304
P356
10.1097/01.AIDS.0000244211.33876.6F
P407
P577
2006-09-01T00:00:00Z